美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Skye Bioscience Inc.

0.8251

+0.04175.32%

盤後：0.8200-0.0051-0.62%19:52 EDT

成交量：21.60萬

成交額：17.18萬

市值：2,898.32萬

市盈率：-0.59

高：0.8298

開：0.8000

低：0.7685

收：0.7834

52周最高：5.75

52周最低：0.5655

股本：3,512.69萬

流通股本：2,295.16萬

量比：0.90

換手率：0.94%

股息：- -

股息率：- -

每股收益(TTM):-1.4100

每股收益(LYR):-1.4100

淨資產收益率：-126.85%

總資產收益率：-71.93%

市淨率：1.45

市盈率(LYR):-0.59

資料載入中...

總覽公司新聞資訊公告

BUZZ--美國股票走勢-特斯拉、藍貓頭鷹、福特

BUZZ-斯凱生物科學公司開始測試更大劑量的肥胖症藥物，業績上升

Skye Bioscience啓動尼瑪西單抗高劑量擴展研究首位患者給藥評估暴露-反應為GLP-1聯合療法二期B階段劑量選擇提供依據

Skye Bioscience, Inc.盤中異動早盤股價大漲7.52%

Skye公布Nimacimab聯合司美格魯肽Cbeyond二期a階段擴展研究積極中期結果

Skye Bioscience Inc. 聯合療法52周減重22.3%：Nimacimab聯合司美格魯肽（2.4毫克）展現顯著成效

BUZZ-與 Halozyme 合作開發肥胖症藥物，Skye 生物科學公司業績攀升

Skye Bioscience Inc.計劃於2026年年中啓動Nimacimab聯合Enhanze技術治療肥胖症的2B期臨床試驗

奧洛茲美醫療與Skye Bioscience達成全球合作與許可協議，共同評估Nimacimab與Enhanze®複方製劑用於肥胖症治療

Skye Bioscience, Inc.盤中異動股價大跌5.13%報0.740美元

Skye Bioscience, Inc.盤中異動股價大跌5.17%

Skye Bioscience, Inc.盤中異動快速下挫5.34%報1.24美元

Skye Bioscience, Inc.盤中異動早盤快速上漲6.85%報1.56美元

Skye Bioscience, Inc.盤中異動早盤股價大漲5.52%

Skye Bioscience, Inc.盤中異動早盤股價大漲5.26%報1.40美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SKYE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SKYE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":0.8251,"timestamp":1776801600000,"preClose":0.7834,"halted":0,"volume":216029,"hourTrading":{"tag":"盘后","latestPrice":0.82,"preClose":0.8251,"latestTime":"19:52 EDT","volume":7394,"amount":6059.4242,"timestamp":1776815562461,"change":-0.0051,"changeRate":-0.006181,"amplitude":0.013817},"delay":0,"changeRate":0.053229512381924894,"floatShares":22951600,"shares":35126884,"eps":-1.410011,"marketStatus":"未開盤","change":0.0417,"latestTime":"04-21 16:00:00 EDT","open":0.8,"high":0.8298,"low":0.7685,"amount":171754.2236993,"amplitude":0.078249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.410011,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776844800000},"marketStatusCode":0,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.7834,"preHourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":0.7834,"latestTime":"09:26 EDT","volume":99,"amount":76.615803,"timestamp":1776777981096,"change":0.0166,"changeRate":0.02119,"amplitude":0.045188},"postHourTrading":{"tag":"盘后","latestPrice":0.82,"preClose":0.8251,"latestTime":"19:52 EDT","volume":7394,"amount":6059.4242,"timestamp":1776815562461,"change":-0.0051,"changeRate":-0.006181,"amplitude":0.013817},"volumeRatio":0.895505,"impliedVol":1.1162,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","floatShares":22951600,"roa":"-71.93%","roe":"-126.85%","lyrEps":-1.410011,"volumeRatio":0.895505,"shares":35126884,"dividePrice":0,"high":0.8298,"amplitude":0.078249,"preClose":0.7834,"low":0.7685,"week52Low":0.5655,"pbRate":"1.45","week52High":5.75,"institutionHeld":0,"latestPrice":0.8251,"eps":-1.410011,"divideRate":0,"volume":216029,"delay":0,"ttmEps":-1.410011,"open":0.8,"prevYearClose":0.7497,"prevWeekClose":0.7889,"prevMonthClose":0.6146,"prevQuarterClose":0.6146,"fiveDayClose":0.8152,"twentyDayClose":0.6418,"sixtyDayClose":1.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SKYE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"SKYE","fiscalQuarterEnding":"2025/12","expectedEps":-0.29,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-11-10","symbol":"SKYE","fiscalQuarterEnding":"2025/09","expectedEps":-0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2025-08-07","symbol":"SKYE","fiscalQuarterEnding":"2025/06","expectedEps":-0.34,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2025-05-08","symbol":"SKYE","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-03-20","symbol":"SKYE","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SKYE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SKYE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1759809600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SKYE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SKYE","date":"2026-04-20","current":-0.585173,"percent":0.9182,"low":-12.94129,"twenty":-4.519197,"median":-2.929772,"eighty":-0.81099,"high":-0.344383,"avg":-3.340081,"sd":2.594325,"marketCap":26332506},"quantilePoints":[{"date":"2024-04-12","current":-9.459964,"twenty":-9.513638,"median":-9.459964,"eighty":-7.885539,"marketCap":356118289},{"date":"2024-04-19","current":-12.650558,"twenty":-12.435864,"median":-9.657512,"eighty":-9.495746,"marketCap":476227531},{"date":"2024-04-26","current":-9.579238,"twenty":-12.081022,"median":-9.691058,"eighty":-9.561347,"marketCap":360608354},{"date":"2024-05-03","current":-9.683603,"twenty":-11.635233,"median":-9.68733,"eighty":-9.561347,"marketCap":364537161},{"date":"2024-05-10","current":-8.997775,"twenty":-10.807766,"median":-9.638876,"eighty":-9.507673,"marketCap":338719287},{"date":"2024-05-17","current":-9.168,"twenty":-10.15772,"median":-9.601602,"eighty":-9.22813,"marketCap":343770610},{"date":"2024-05-24","current":-8.952556,"twenty":-9.700003,"median":-9.54942,"eighty":-8.9931,"marketCap":335692167},{"date":"2024-05-31","current":-8.720508,"twenty":-9.691058,"median":-9.489815,"eighty":-8.983995,"marketCap":326991116},{"date":"2024-06-07","current":-8.47349,"twenty":-9.691058,"median":-9.389145,"eighty":-8.952556,"marketCap":317728707},{"date":"2024-06-14","current":-8.069277,"twenty":-9.691058,"median":-9.18753,"eighty":-8.690567,"marketCap":302572037},{"date":"2024-06-21","current":-6.684476,"twenty":-9.685094,"median":-9.060284,"eighty":-8.473188,"marketCap":250646409},{"date":"2024-06-28","current":-5.434411,"twenty":-9.674658,"median":-9.022864,"eighty":-8.245631,"marketCap":203773004},{"date":"2024-07-05","current":-5.58412,"twenty":-9.638876,"median":-8.993879,"eighty":-7.844715,"marketCap":209386586},{"date":"2024-07-12","current":-4.873005,"twenty":-9.631421,"median":-8.980898,"eighty":-7.11863,"marketCap":182722074},{"date":"2024-07-15","current":-4.820607,"twenty":-9.62993,"median":-8.974213,"eighty":-6.892464,"marketCap":180757321},{"date":"2024-08-02","current":-4.102007,"twenty":-9.628439,"median":-8.967527,"eighty":-6.745055,"marketCap":153812130},{"date":"2024-08-09","current":-3.735222,"twenty":-9.606075,"median":-8.870216,"eighty":-5.58412,"marketCap":140058855},{"date":"2024-08-16","current":-3.615791,"twenty":-9.579238,"median":-8.690567,"eighty":-4.690361,"marketCap":152904981},{"date":"2024-08-23","current":-3.787972,"twenty":-9.567311,"median":-8.506414,"eighty":-4.17237,"marketCap":160186171},{"date":"2024-08-30","current":-4.584307,"twenty":-9.543456,"median":-8.189044,"eighty":-4.185844,"marketCap":193861673},{"date":"2024-09-06","current":-4.347559,"twenty":-9.525571,"median":-8.069277,"eighty":-4.204574,"marketCap":183850037},{"date":"2024-09-13","current":-4.304513,"twenty":-9.489808,"median":-7.545298,"eighty":-4.204574,"marketCap":182029740},{"date":"2024-09-20","current":-3.93863,"twenty":-9.483818,"median":-7.11863,"eighty":-4.170873,"marketCap":166557212},{"date":"2024-09-27","current":-2.840979,"twenty":-9.431636,"median":-6.35886,"eighty":-4.072065,"marketCap":120139628},{"date":"2024-10-04","current":-2.56836,"twenty":-9.296072,"median":-5.58412,"eighty":-3.802872,"marketCap":108611078},{"date":"2024-10-11","current":-2.683147,"twenty":-9.199248,"median":-5.224584,"eighty":-3.740033,"marketCap":113465204},{"date":"2024-10-18","current":-3.034682,"twenty":-9.153032,"median":-4.873005,"eighty":-3.308736,"marketCap":128330966},{"date":"2024-10-25","current":-3.501004,"twenty":-9.080009,"median":-4.593919,"eighty":-3.325954,"marketCap":148050855},{"date":"2024-10-31","current":-3.651662,"twenty":-9.02741,"median":-4.557114,"eighty":-3.343172,"marketCap":154421896},{"date":"2024-11-08","current":-7.770049,"twenty":-9.018318,"median":-4.55561,"eighty":-3.379043,"marketCap":165040297},{"date":"2024-11-15","current":-7.870031,"twenty":-8.997775,"median":-4.571462,"eighty":-3.501004,"marketCap":167163977},{"date":"2024-11-22","current":-5.956085,"twenty":-8.989983,"median":-4.820607,"eighty":-3.501004,"marketCap":126510669},{"date":"2024-11-29","current":-6.413147,"twenty":-8.983995,"median":-4.921494,"eighty":-3.53544,"marketCap":136218922},{"date":"2024-12-06","current":-5.070528,"twenty":-8.981218,"median":-5.25247,"eighty":-3.595703,"marketCap":107700929},{"date":"2024-12-13","current":-4.784865,"twenty":-8.970201,"median":-5.21336,"eighty":-3.614356,"marketCap":101633271},{"date":"2024-12-20","current":-4.084989,"twenty":-8.95555,"median":-5.042643,"eighty":-3.644488,"marketCap":86767509},{"date":"2024-12-27","current":-3.799325,"twenty":-8.952556,"median":-4.89725,"eighty":-3.64221,"marketCap":80699851},{"date":"2025-01-03","current":-4.070706,"twenty":-8.886684,"median":-4.82416,"eighty":-3.64221,"marketCap":86464126},{"date":"2025-01-10","current":-4.427785,"twenty":-8.774403,"median":-4.734873,"eighty":-3.64221,"marketCap":94048699},{"date":"2025-01-17","current":-3.856458,"twenty":-8.71452,"median":-4.60353,"eighty":-3.6441,"marketCap":81913383},{"date":"2025-01-24","current":-3.727909,"twenty":-8.690567,"median":-4.558618,"eighty":-3.651662,"marketCap":79182936},{"date":"2025-01-31","current":-5.356192,"twenty":-8.660625,"median":-4.557114,"eighty":-3.694707,"marketCap":113768587},{"date":"2025-02-07","current":-4.256387,"twenty":-8.539337,"median":-4.55561,"eighty":-3.699343,"marketCap":90408104},{"date":"2025-02-14","current":-4.370652,"twenty":-8.47349,"median":-4.466458,"eighty":-3.699343,"marketCap":92835167},{"date":"2025-02-21","current":-4.470635,"twenty":-8.472282,"median":-4.477777,"eighty":-3.722196,"marketCap":94958847},{"date":"2025-02-28","current":-3.827892,"twenty":-8.245631,"median":-4.442068,"eighty":-3.730044,"marketCap":81306617},{"date":"2025-03-07","current":-3.670777,"twenty":-8.162365,"median":-4.40636,"eighty":-3.699343,"marketCap":77969405},{"date":"2025-03-14","current":-3.463671,"twenty":-8.134468,"median":-4.354733,"eighty":-3.698416,"marketCap":73570353},{"date":"2025-03-21","current":-2.203547,"twenty":-8.081254,"median":-4.304513,"eighty":-3.649772,"marketCap":58541914},{"date":"2025-03-28","current":-2.471704,"twenty":-7.90988,"median":-4.297339,"eighty":-3.6255,"marketCap":65666062},{"date":"2025-04-04","current":-1.632257,"twenty":-7.858605,"median":-4.256387,"eighty":-3.582221,"marketCap":43364381},{"date":"2025-04-11","current":-1.562303,"twenty":-7.846922,"median":-4.225597,"eighty":-3.501004,"marketCap":41505907},{"date":"2025-04-17","current":-1.842119,"twenty":-7.799915,"median":-4.189726,"eighty":-3.364695,"marketCap":48939801},{"date":"2025-04-25","current":-2.086958,"twenty":-7.727199,"median":-4.165203,"eighty":-3.259602,"marketCap":55444458},{"date":"2025-05-02","current":-2.366773,"twenty":-7.630073,"median":-4.156405,"eighty":-3.056205,"marketCap":62878352},{"date":"2025-05-09","current":-1.698098,"twenty":-7.560926,"median":-4.127838,"eighty":-2.911286,"marketCap":55444458},{"date":"2025-05-16","current":-1.907406,"twenty":-7.545298,"median":-4.116978,"eighty":-2.799369,"marketCap":62278559},{"date":"2025-05-23","current":-1.964344,"twenty":-7.500386,"median":-4.077848,"eighty":-2.746856,"marketCap":64137621},{"date":"2025-05-30","current":-2.011792,"twenty":-7.329718,"median":-4.070706,"eighty":-2.683147,"marketCap":65686838},{"date":"2025-06-06","current":-2.040261,"twenty":-7.099247,"median":-4.06458,"eighty":-2.616276,"marketCap":66616369},{"date":"2025-06-13","current":-2.05924,"twenty":-6.976473,"median":-4.013573,"eighty":-2.54373,"marketCap":67236056},{"date":"2025-06-20","current":-2.030771,"twenty":-6.805634,"median":-3.979786,"eighty":-2.387759,"marketCap":66306526},{"date":"2025-06-27","current":-4.033073,"twenty":-6.650207,"median":-3.970723,"eighty":-2.387759,"marketCap":131683521},{"date":"2025-07-03","current":-4.374698,"twenty":-6.513129,"median":-3.970723,"eighty":-2.471704,"marketCap":142837890},{"date":"2025-07-11","current":-3.738896,"twenty":-6.413147,"median":-3.970723,"eighty":-2.503792,"marketCap":122078370},{"date":"2025-07-18","current":-3.530125,"twenty":-6.413147,"median":-3.966646,"eighty":-2.541658,"marketCap":115261811},{"date":"2025-07-25","current":-3.805323,"twenty":-6.298881,"median":-3.947535,"eighty":-2.546837,"marketCap":124247275},{"date":"2025-08-01","current":-3.387782,"twenty":-6.198899,"median":-3.902759,"eighty":-2.561185,"marketCap":110614158},{"date":"2025-08-08","current":-3.368802,"twenty":-6.1132,"median":-3.885025,"eighty":-2.56836,"marketCap":109994470},{"date":"2025-08-15","current":-2.391434,"twenty":-6.1132,"median":-3.856458,"eighty":-2.546837,"marketCap":101332133},{"date":"2025-08-22","current":-2.596205,"twenty":-6.1132,"median":-3.856458,"eighty":-2.541658,"marketCap":110008891},{"date":"2025-08-29","current":-2.545012,"twenty":-6.033244,"median":-3.838191,"eighty":-2.530385,"marketCap":107839701},{"date":"2025-09-05","current":-2.74247,"twenty":-6.003302,"median":-3.805323,"eighty":-2.498872,"marketCap":116206575},{"date":"2025-09-12","current":-3.115445,"twenty":-5.964031,"median":-3.793648,"eighty":-2.525066,"marketCap":132010669},{"date":"2025-09-19","current":-2.881421,"twenty":-5.898952,"median":-3.776855,"eighty":-2.539403,"marketCap":122094374},{"date":"2025-09-26","current":-2.632771,"twenty":-5.861816,"median":-3.757875,"eighty":-2.544341,"marketCap":111558312},{"date":"2025-10-03","current":-3.28365,"twenty":-5.684705,"median":-3.738896,"eighty":-2.546472,"marketCap":139138005},{"date":"2025-10-10","current":-1.257879,"twenty":-5.595667,"median":-3.729992,"eighty":-2.525066,"marketCap":53300082},{"date":"2025-10-17","current":-1.060422,"twenty":-5.58412,"median":-3.727909,"eighty":-2.468814,"marketCap":44933209},{"date":"2025-10-24","current":-1.060422,"twenty":-5.516043,"median":-3.699343,"eighty":-2.388509,"marketCap":44933209},{"date":"2025-10-31","current":-1.075048,"twenty":-5.447334,"median":-3.691448,"eighty":-2.317303,"marketCap":45552977},{"date":"2025-11-07","current":-1.111614,"twenty":-5.371836,"median":-3.676368,"eighty":-2.244599,"marketCap":47102398},{"date":"2025-11-14","current":-0.828708,"twenty":-5.321912,"median":-3.651662,"eighty":-2.178806,"marketCap":42454135},{"date":"2025-11-21","current":-0.782205,"twenty":-5.233356,"median":-3.64221,"eighty":-2.124921,"marketCap":40071826},{"date":"2025-11-28","current":-0.819751,"twenty":-5.18765,"median":-3.621859,"eighty":-2.093402,"marketCap":41995273},{"date":"2025-12-05","current":-0.757174,"twenty":-5.110521,"median":-3.608617,"eighty":-2.055444,"marketCap":38789527},{"date":"2025-12-12","current":-0.719628,"twenty":-5.037066,"median":-3.577936,"eighty":-2.025264,"marketCap":36866080},{"date":"2025-12-19","current":-0.625701,"twenty":-4.9588,"median":-3.549105,"eighty":-1.981949,"marketCap":32054255},{"date":"2025-12-26","current":-0.522137,"twenty":-4.912548,"median":-3.544049,"eighty":-1.945365,"marketCap":26748745},{"date":"2026-01-02","current":-0.469135,"twenty":-4.89913,"median":-3.530125,"eighty":-1.880836,"marketCap":24033478},{"date":"2026-01-09","current":-0.657052,"twenty":-4.893905,"median":-3.501657,"eighty":-1.841207,"marketCap":33660334},{"date":"2026-01-16","current":-0.60236,"twenty":-4.863947,"median":-3.501004,"eighty":-1.780246,"marketCap":30858511},{"date":"2026-01-23","current":-0.657052,"twenty":-4.827714,"median":-3.463671,"eighty":-1.698098,"marketCap":33660334},{"date":"2026-01-30","current":-0.600733,"twenty":-4.820607,"median":-3.430485,"eighty":-1.632257,"marketCap":30775162},{"date":"2026-02-06","current":-0.500298,"twenty":-4.784865,"median":-3.387782,"eighty":-1.562303,"marketCap":25629940},{"date":"2026-02-13","current":-0.451176,"twenty":-4.684882,"median":-3.355987,"eighty":-1.389518,"marketCap":23113429},{"date":"2026-02-20","current":-0.488221,"twenty":-4.650603,"median":-3.310888,"eighty":-1.249103,"marketCap":25011231},{"date":"2026-02-27","current":-0.482464,"twenty":-4.611231,"median":-3.270848,"eighty":-1.139404,"marketCap":24716302},{"date":"2026-03-06","current":-0.461814,"twenty":-4.588626,"median":-3.232166,"eighty":-1.117465,"marketCap":23658406},{"date":"2026-03-13","current":-0.421973,"twenty":-4.584426,"median":-3.115445,"eighty":-1.099913,"marketCap":23598786},{"date":"2026-03-20","current":-0.391057,"twenty":-4.563756,"median":-3.07414,"eighty":-1.060422,"marketCap":21869766},{"date":"2026-03-27","current":-0.368854,"twenty":-4.556212,"median":-3.020373,"eighty":-1.032631,"marketCap":20628076},{"date":"2026-04-02","current":-0.396846,"twenty":-4.55561,"median":-3.01306,"eighty":-0.904924,"marketCap":22193540},{"date":"2026-04-10","current":-0.433194,"twenty":-4.547475,"median":-2.991518,"eighty":-0.825125,"marketCap":24226306},{"date":"2026-04-17","current":-0.447638,"twenty":-4.524911,"median":-2.934243,"eighty":-0.813493,"marketCap":25034073},{"date":"2026-04-20","current":-0.470855,"twenty":-4.519197,"median":-2.929772,"eighty":-0.81099,"marketCap":26332506}],"updateTime":1776832924904},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SKYE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624034688","title":"BUZZ--美國股票走勢-特斯拉、藍貓頭鷹、福特","url":"https://stock-news.laohu8.com/highlight/detail?id=2624034688","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624034688?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 23:49","pubTimestamp":1775144981,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.11%，报46,514.09点；标普500指数.SPX上涨0.03%，报6,577.02点；纳斯达克综合指数.IXIC下跌0.02%，报21,836.06点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4T40L1HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","FCX","LMT","XOMO","CVX","CLDX","TSLA","LPCN","EL","SCCO","TSLQ","WING","IMVT","TESL","COP","HMH","JBHT","KRP","RIVN","SNBR","AAL","TSLY","XOMZ","RVNL","TSLR","AALG","LUV","HL","OWL","TSLO","XOM","GSAT","CNTX","SKYE","CDE","TSDD","DAL","NEM","TSLP","DVN","TSLI","LNN","NWMX","07766","OXY","UAL","COCP","NOC","XOMX","SBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624505203","title":"BUZZ-斯凱生物科學公司開始測試更大劑量的肥胖症藥物，業績上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2624505203","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624505203?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:45","pubTimestamp":1775130345,"startTime":"0","endTime":"0","summary":"BUZZ-斯凯生物科学公司开始测试更大剂量的肥胖症药物，业绩上升4月2日 - ** 生物技术公司斯凯生物科学SKYE.O股价盘前上涨1.2%至0.67美元** 该公司称已开始在一项新的扩展研究中测试其试验性肥胖症药物尼马单抗的更高剂量 ** 补充说，这项研究将在16周内测试400毫克和600毫克的静脉注射剂量，以检查药物的安全性以及药物在体内的移动情况，并与安慰剂进行对比。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4S40L0YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196567670","title":"Skye Bioscience啓動尼瑪西單抗高劑量擴展研究首位患者給藥 評估暴露-反應為GLP-1聯合療法二期B階段劑量選擇提供依據","url":"https://stock-news.laohu8.com/highlight/detail?id=1196567670","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196567670?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:02","pubTimestamp":1775127720,"startTime":"0","endTime":"0","summary":"生物制药企业Skye Bioscience Inc. (NASDAQ: SKYE) 近日迎来重大研发进展——其针对尼玛西单抗（nimacimab）开展的高剂量扩展研究已完成首例患者给药。该研究旨在通过评估药物暴露-反应关系，为后续GLP-1联合疗法的二期B阶段临床实验确定最佳剂量方案提供关键数据支持。\n此次剂量扩展研究的启动，标志着Skye Bioscience在代谢性疾病治疗领域迈出实质性步伐。通过精准分析不同剂量水平下尼玛西单抗在人体内的代谢动力学与药效学关联，研究团队期望为二期B阶段剂量选择奠定科学基础，进而加速GLP-1受体激动剂联合疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608435001","title":"Skye Bioscience, Inc.盤中異動 早盤股價大漲7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608435001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608435001?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 22:33","pubTimestamp":1770129201,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日22时33分，Skye Bioscience, Inc.股票出现异动，股价大幅拉升7.52%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、阿诺医药、Caribou Biosciences, Inc.涨幅较大，Cdt Equity Inc.、Pmgc Holdings Inc.、Liminatus Pharma, Inc.较为活跃，换手率分别为607.48%、564.49%、42.37%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、阿诺医药、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为32.58%、13.48%、11.01%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223322a6cef695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223322a6cef695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167741515","title":"Skye公布Nimacimab聯合司美格魯肽Cbeyond二期a階段擴展研究積極中期結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167741515","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167741515?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 20:08","pubTimestamp":1770034126,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.（简称“Skye”）近日披露了其创新药物Nimacimab与司美格鲁肽（Semaglutide）联合用药的Cbeyond二期a阶段扩展研究的中期分析数据，结果显示疗效积极。\n这项扩展研究旨在评估Nimacimab与司美格鲁肽联合治疗方案在特定患者群体中的长期安全性与有效性。中期数据表明，联合用药在关键疗效指标上表现出显著改善，且安全性和耐受性良好，未出现新的不良反应信号。\n研究结果的积极进展为Nimacimab的后续临床开发提供了有力支持，也为相关疾病领域的治疗带来了新的潜在选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106684585","title":"Skye Bioscience Inc. 聯合療法52周減重22.3%：Nimacimab聯合司美格魯肽（2.4毫克）展現顯著成效","url":"https://stock-news.laohu8.com/highlight/detail?id=1106684585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106684585?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 20:06","pubTimestamp":1770034013,"startTime":"0","endTime":"0","summary":"在为期52周的临床研究中，Skye Bioscience Inc. 所开发的Nimacimab与司美格鲁肽（2.4毫克）联合疗法取得了令人瞩目的成果，受试者体重平均下降幅度达到22.3%。这一数据凸显了该联合方案在体重管理领域的巨大潜力。\nNimacimab作为一种创新治疗成分，与已广泛应用的司美格鲁肽协同作用，显示出优于单一疗法的减重效果。研究结果不仅证实了联合用药的安全性，更为其在肥胖治疗领域的应用前景提供了有力支持。\n未来，Skye Bioscience Inc. 将继续推进相关临床研究，进一步探索该联合疗法的长期疗效与适用范围，为全球肥胖患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601886640","title":"BUZZ-與 Halozyme 合作開發肥胖症藥物，Skye 生物科學公司業績攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886640","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601886640?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:13","pubTimestamp":1767615231,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nL4T3Y60SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139","LU0053671581.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158508067","title":"Skye Bioscience Inc.計劃於2026年年中啓動Nimacimab聯合Enhanze技術治療肥胖症的2B期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1158508067","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158508067?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:03","pubTimestamp":1767614583,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.近日公布其研发战略，计划在2026年中期正式启动一项针对肥胖症治疗的2B期临床试验。该试验将重点评估其核心候选药物Nimacimab与奥洛兹美医疗（Halozyme Therapeutics）专有的Enhanze药物递送技术联合应用的疗效与安全性。\n这一临床进展标志着Skye在代谢疾病治疗领域迈出了关键一步。Nimacimab作为一种创新疗法，结合Enhanze技术旨在增强药物递送效率，有望为肥胖患者提供新的治疗选择。公司预计该试验将为后续临床开发提供重要数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","HALO","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162485011","title":"奧洛茲美醫療與Skye Bioscience達成全球合作與許可協議，共同評估Nimacimab與Enhanze®複方製劑用於肥胖症治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1162485011","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162485011?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:02","pubTimestamp":1767614523,"startTime":"0","endTime":"0","summary":"奥洛兹美医疗与Skye Bioscience公司宣布，双方已签署一项全球性的合作与许可协议。该协议的核心内容是，将共同评估Nimacimab与奥洛兹美医疗的Enhanze®药物递送技术共同配制的复方制剂，用于治疗肥胖症的潜力。此次合作旨在结合两家公司的专长，探索这一创新疗法在代谢疾病领域的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","LU0053671581.USD","BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595108746","title":"Skye Bioscience, Inc.盤中異動 股價大跌5.13%報0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595108746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595108746?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 22:32","pubTimestamp":1767105157,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日22时32分，Skye Bioscience, Inc.股票出现异动，股价急速跳水5.13%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Dermata Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1408.00%、503.15%、30.62%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Dermata Therapeutics, Inc.、Coya Therapeutics, Inc.，振幅分别为20.95%、9.67%、9.01%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223237a48ac17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223237a48ac17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593649611","title":"Skye Bioscience, Inc.盤中異動 股價大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593649611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593649611?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 23:05","pubTimestamp":1766415957,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时05分，Skye Bioscience, Inc.股票出现波动，股价急速下跌5.17%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、健永生技、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃，换手率分别为121.62%、43.55%、17.08%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、健永生技、Equillium, Inc.，振幅分别为103.24%、59.29%、24.34%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230557a6c203fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230557a6c203fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588726807","title":"Skye Bioscience, Inc.盤中異動 快速下挫5.34%報1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726807?lang=zh_tw&edition=fundamental","pubTime":"2025-12-01 23:26","pubTimestamp":1764602819,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时26分，Skye Bioscience, Inc.股票出现异动，股价大幅下挫5.34%。截至发稿，该股报1.24美元/股，成交量3.3126万股，换手率0.10%，振幅3.82%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012326599524ed5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012326599524ed5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583650580","title":"Skye Bioscience, Inc.盤中異動 早盤快速上漲6.85%報1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583650580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583650580?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 22:57","pubTimestamp":1762959450,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时57分，Skye Bioscience, Inc.股票出现异动，股价快速上涨6.85%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为5706.48%、329.96%、221.30%，振幅较大的相关个股有Leap Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.，振幅分别为60.41%、47.55%、43.88%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112225730950022a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112225730950022a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578542183","title":"Skye Bioscience, Inc.盤中異動 早盤股價大漲5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578542183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578542183?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 21:56","pubTimestamp":1761314215,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时56分，Skye Bioscience, Inc.股票出现异动，股价急速拉升5.52%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Genenta Science Spa、Neuphoria Therapeutics Inc.、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2127.42%、1972.80%、1225.21%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genenta Science Spa、Neuphoria Therapeutics Inc.，振幅分别为69.66%、66.25%、63.95%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215655974093d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215655974093d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577338488","title":"Skye Bioscience, Inc.盤中異動 早盤股價大漲5.26%報1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577338488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577338488?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 22:27","pubTimestamp":1761056869,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日22时27分，Skye Bioscience, Inc.股票出现异动，股价大幅拉升5.26%。Skye Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1474.81%、202.88%、92.68%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、88.41%、47.03%。Skye Bioscience, Inc.公司简介：Skye Bioscience Inc 是一家位于加利福尼亚州圣地亚哥的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021222749a46c8ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021222749a46c8ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}